Trials / Completed
CompletedNCT04353583
Acute Kidney Injury and Acute Kidney Disease in COVID-19
Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD) in Patients With Coronavirus Disease 2019 (COVID-19)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (actual)
- Sponsor
- University of Giessen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
Detailed description
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients show severe kidney abnormalities. Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
Conditions
Timeline
- Start date
- 2020-04-21
- Primary completion
- 2022-05-17
- Completion
- 2025-02-01
- First posted
- 2020-04-20
- Last updated
- 2025-03-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04353583. Inclusion in this directory is not an endorsement.